TNXP: PDUFA Date for TNX-102 SL in Fibromyalgia of August 15, 2025
On December 23, 2024, Tonix Pharmaceuticals Holding Corp. (TNXP) announced that the FDA has assigned a Prescription Drug User Fee Act (PDUFA) goal...
What is covered in the Full Insight:
- Business Update
- PDUFA Date for TNX-102 SL
- Financial Status
- Clinical Trials and Market Potential
- Risk Assessment
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 11-minute read)
Related Insights
More »- TNXP: 2Q25 Financial Update and Deep Dive Into TNX-1500
- TNXP: 2Q25 Financial Update and Deep Dive Into TNX-1500
- TNXP: Preparations Continue for Potential Commercial Launch of TNX-102 SL in Fibromyalgia
- TNXP: No AdCom Required for TNX-102 SL NDA
- TNXP: PDUFA Date for TNX-102 SL in Fibromyalgia of August 15, 2025
Trending Collections
More »Trending Insights
More »- WuXi AppTec (2359 HK) Placement: Strong Momentum & Index Flows
- [Japan M&A] YAGEO Extends Shibaura TOB Limbo at FSA/METI/BOJ Request on FEFTA
- ECB Job Tightened By Jobs
- Bank of Japan’s Rate Decision on 31 July: Market Calm, Watch for Tail Risk
- Petrindo Jaya Kreasi (CUAN IJ): Potential Global Index Inclusion & The Risks
Top Unpaywalled Insights
More »- Bond Market Monitor: Thailand Unsmiled
- Indian Banking’s Longest-Serving, Highest-Paid HR-Head Quits IndusInd Bank
- [IO Technicals 2025/30] Iron Ore Rally Cools on Supply Surge, but Policy Hopes Keep Prices Afloat
- New Barbarians Podcast | Episode #029 | Recap & Reset: Macro Shifts, Ethereum's Spike, MicroStrat...
- Crypto Week Unleashes a Bitcoin Blitz and Sparks the Altcoin Catch-Up
Discussions
(Paid Plans Only)
x